Neurolixis' Grant - II Round

Neurolixis raised a round of funding on March 21, 2014. Investors include The Michael J. Fox Foundation.

Neurolixis is an early-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of human central nervous system diseases including Parkins…

Articles about Neurolixis' Grant - II Round: